Study finds about 13 percent of parental figures between the ages of 18 and 40 regret having children
ClinicalNew experimental treatment may boost cognitive function in fragile X syndromeThe phase 2 randomized, placebo-controlled trial involved 30 participants in early and mid-adulthood. Read More
ClinicalResearchers are in the midst of a breakthrough treatment for Fragile X syndromeThe findings were the result of phase 2 clinical trials testing the phosphodiesterase‐4D inhibitor BPN14770. Read More
